Azithromycin Dosing for Typhoid Fever
For uncomplicated typhoid fever, use azithromycin 20 mg/kg once daily (maximum 1 g/day in adults) for 7 days, which provides superior outcomes compared to fluoroquinolones and comparable efficacy to ceftriaxone. 1
Recommended Dosing Regimen
Adults
Children
- 20 mg/kg once daily (maximum 1 g/day) for 7 days 2
- Some studies have used 20 mg/kg/day for 6 days with good efficacy 4
Evidence Supporting This Recommendation
The 2024 WHO Essential Medicines guideline recommends azithromycin as a second-line agent for quinolone-resistant typhoid fever 1. However, the most recent high-quality evidence from the 2026 ACT-South Asia trial (n=1,831 participants across Nepal, Bangladesh, and Pakistan) demonstrated that azithromycin monotherapy achieved treatment failure rates of only 5.1% in clinically suspected cases and 16% in culture-confirmed cases 2. This large, well-designed trial found no benefit to adding cefixime to azithromycin, supporting azithromycin monotherapy as the optimal approach.
Key Performance Metrics
Azithromycin demonstrates:
- Lower clinical failure rates compared to fluoroquinolones (OR 0.48,95% CI 0.26-0.89) 1
- Shorter hospital stays by approximately 1 day compared to fluoroquinolones 1
- Significantly lower relapse rates compared to ceftriaxone (OR 0.09,95% CI 0.01-0.70) 1
- Mean fever clearance time of 3.45 days in pediatric studies 4
Clinical Context and Resistance Considerations
When to Use Azithromycin
Azithromycin is particularly valuable in:
- Quinolone-resistant typhoid (common in South Asia where nalidixic acid resistance exceeds 90%) 5
- Multidrug-resistant strains (resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole) 3
- Outpatient management of uncomplicated cases 2
Extensively Drug-Resistant (XDR) Typhoid
For XDR strains (resistant to fluoroquinolones, third-generation cephalosporins, AND azithromycin), consider:
- Azithromycin plus meropenem combination 6
- This scenario requires hospitalization and infectious disease consultation
Important Caveats
Do not combine azithromycin with cefixime routinely. The 2026 ACT-South Asia trial definitively showed no benefit to combination therapy (treatment failure 5.1% in both groups, p=1.00) 2. This has critical antimicrobial stewardship implications—adding cefixime increases cost, adverse effects, and resistance pressure without improving outcomes.
MIC interpretation challenges exist. Disc diffusion testing shows 1.9% false-resistance rates for azithromycin 7. Time-kill assays demonstrate azithromycin has slow bacteriostatic (not bactericidal) activity against S. Typhi 7, which explains the gradual fever clearance over 3-4 days rather than rapid defervescence.
Treatment failure indicators requiring escalation or combination therapy:
- Fever persisting ≥7 days on appropriate therapy
- Clinical deterioration during treatment
- Development of complications (intestinal perforation, encephalopathy)
- Positive blood cultures at day 7
Practical Administration
- Give as a single daily dose (improves adherence) 2
- Can be administered with or without food, though food increases Cmax by 56% without affecting overall absorption 8
- No dose adjustment needed for mild-moderate renal impairment 8
- Achieves excellent tissue penetration with lung concentrations >100-fold higher than serum 8
The evidence strongly supports 7-day azithromycin monotherapy as the optimal balance of efficacy, safety, convenience, and antimicrobial stewardship for uncomplicated typhoid fever in both adults and children.